BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 28939253)

  • 21. Transactivation Assays that Identify Indirect and Direct Activators of Human Pregnane X Receptor (PXR, NR1I2) and Constitutive Androstane Receptor (CAR, NR1I3).
    Pinne M; Ponce E; Raucy JL
    Drug Metab Lett; 2017; 11(2):128-137. PubMed ID: 29219065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular basis of crosstalk in nuclear receptors: heterodimerization between PXR and CAR and the implication in gene regulation.
    Bwayi MN; Garcia-Maldonado E; Chai SC; Xie B; Chodankar S; Huber AD; Wu J; Annu K; Wright WC; Lee HM; Seetharaman J; Wang J; Buchman CD; Peng J; Chen T
    Nucleic Acids Res; 2022 Apr; 50(6):3254-3275. PubMed ID: 35212371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulatory cross-talk between drug metabolism and lipid homeostasis: constitutive androstane receptor and pregnane X receptor increase Insig-1 expression.
    Roth A; Looser R; Kaufmann M; Blättler SM; Rencurel F; Huang W; Moore DD; Meyer UA
    Mol Pharmacol; 2008 Apr; 73(4):1282-9. PubMed ID: 18187584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The nuclear xenobiotic receptor CAR: structural determinants of constitutive activation and heterodimerization.
    Suino K; Peng L; Reynolds R; Li Y; Cha JY; Repa JJ; Kliewer SA; Xu HE
    Mol Cell; 2004 Dec; 16(6):893-905. PubMed ID: 15610733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of human CYP2A6 is mediated by the pregnane X receptor with peroxisome proliferator-activated receptor-gamma coactivator 1alpha.
    Itoh M; Nakajima M; Higashi E; Yoshida R; Nagata K; Yamazoe Y; Yokoi T
    J Pharmacol Exp Ther; 2006 Nov; 319(2):693-702. PubMed ID: 16857725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pregnane and Xenobiotic Receptor (PXR/SXR) resides predominantly in the nuclear compartment of the interphase cell and associates with the condensed chromosomes during mitosis.
    Saradhi M; Sengupta A; Mukhopadhyay G; Tyagi RK
    Biochim Biophys Acta; 2005 Dec; 1746(2):85-94. PubMed ID: 16297466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Organotin compound DBDCT induces CYP3A suppression through NF-κB-mediated repression of PXR activity.
    Li Y; Lin N; Ji X; Mai J; Li Q
    Metallomics; 2019 May; 11(5):936-948. PubMed ID: 30848264
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of hepatocyte RXR alpha in xenobiotic-sensing nuclear receptor-mediated pathways.
    Cai Y; Konishi T; Han G; Campwala KH; French SW; Wan YJ
    Eur J Pharm Sci; 2002 Feb; 15(1):89-96. PubMed ID: 11803135
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Xenosensors CAR and PXR at work: impact on statin metabolism.
    Marino M; di Masi A; Trezza V; Pallottini V; Polticelli F; Ascenzi P
    Curr Drug Metab; 2011 Mar; 12(3):300-11. PubMed ID: 21395534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Helix 11 dynamics is critical for constitutive androstane receptor activity.
    Wright E; Busby SA; Wisecarver S; Vincent J; Griffin PR; Fernandez EJ
    Structure; 2011 Jan; 19(1):37-44. PubMed ID: 21220114
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of drug metabolism: the role of nuclear receptors.
    Handschin C; Meyer UA
    Pharmacol Rev; 2003 Dec; 55(4):649-73. PubMed ID: 14657421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CAR and PXR: the xenobiotic-sensing receptors.
    Timsit YE; Negishi M
    Steroids; 2007 Mar; 72(3):231-46. PubMed ID: 17284330
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Animal models of xenobiotic receptors.
    Dai G; Wan YJ
    Curr Drug Metab; 2005 Aug; 6(4):341-55. PubMed ID: 16101573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nuclear receptors and nonalcoholic fatty liver disease.
    Cave MC; Clair HB; Hardesty JE; Falkner KC; Feng W; Clark BJ; Sidey J; Shi H; Aqel BA; McClain CJ; Prough RA
    Biochim Biophys Acta; 2016 Sep; 1859(9):1083-1099. PubMed ID: 26962021
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacogenomics, regulation and signaling pathways of phase I and II drug metabolizing enzymes.
    Rushmore TH; Kong AN
    Curr Drug Metab; 2002 Oct; 3(5):481-90. PubMed ID: 12369894
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel Application of Red Fluorescent Protein (DsRed-Express) for the Study of Functional Dynamics of Nuclear Receptors.
    Dash AK; Yende AS; Tyagi RK
    J Fluoresc; 2017 Jul; 27(4):1225-1231. PubMed ID: 28470379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retinoid X receptor-alpha-dependent transactivation by a naturally occurring structural variant of human constitutive androstane receptor (NR1I3).
    Auerbach SS; Stoner MA; Su S; Omiecinski CJ
    Mol Pharmacol; 2005 Nov; 68(5):1239-53. PubMed ID: 16099843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vitamin E, nuclear receptors and xenobiotic metabolism.
    Traber MG
    Arch Biochem Biophys; 2004 Mar; 423(1):6-11. PubMed ID: 14989258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thermodynamic characterization of the interaction between CAR-RXR and SRC-1 peptide by isothermal titration calorimetry.
    Wright E; Vincent J; Fernandez EJ
    Biochemistry; 2007 Jan; 46(3):862-70. PubMed ID: 17223708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence for triclosan-induced activation of human and rodent xenobiotic nuclear receptors.
    Paul KB; Thompson JT; Simmons SO; Vanden Heuvel JP; Crofton KM
    Toxicol In Vitro; 2013 Oct; 27(7):2049-60. PubMed ID: 23899473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.